NMMNyaradzo Mavis MgodiMBChB, MMedSlidesetHIVINTEREST 2018Novel HIV prevention methods for women- Nyaradzo Mgodi, MBChB, MMedView Slideset
SlidesetHIVINTEREST 2018Equity not equality of services: Case of HIV Differentiated Service Delivery Model (DSDM) in Rwanda- Muhayimpundu RibakareView Slideset
SlidesetHIVINTEREST 2018The Road to 90-90-90: Progress in HIV prevention and treatment scale-up in sub-Saharan Africa - Karusa Kiragu, PhDView Slideset
SlidesetHIVINTEREST 2018Community perspective on progress in Rwanda- Geraldine Umutesi, BScView Slideset
SlidesetHIVINTEREST 2018Catherine Hankins, MD, PhD, FRCP, CM- Catherine Hankins, MD, PhD, FRCP, CMView Slideset
VideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018Update on DDI guidelines of the FDA - in vitro | Xinning Yang, PhDView Video
GDPGiovanni Di PerriMD, PhDVideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018Clinical Pharmacology of Integrase Inhibitors | Giovanni Di Perri, MD, PhDView Video
ACAndrea CalcagnoMD, DTM&HVideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018Last advances in HIV pharmacogenomics | Andrea Calcagno, MD, DTM&HView Video
VideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018How/when will pharmacogenomics translate into improved clinical care? | David Haas, MDView Video
VideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018Application of Physiologically based pharmacokinetic (PBPK) Modelling to Drug Development Decisions | Joga Gobburu, PhD, MBAView Video
